Injectable Flowable Composition Comprising Buprenorphine

Patent No. EP2579874 (titled "Injectable Flowable Composition Comprising Buprenorphine") was filed by Indivior UK on Jun 6, 2011. The application was issued on Jan 10, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSOct 10, 2018LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2579874

INDIVIOR UK
Application Number
EP11728037A
Filing Date
Jun 6, 2011
Status
Opposition Rejected
Sep 9, 2022
Publication Date
Jan 10, 2018